anonymous
Guest
anonymous
Guest
Interesting comparator in story regarding FDA hold on antibody therapies vs Covid-19 Omicron
https://pharmaphorum.com/news/fda-bans-use-of-lilly-regeneron-covid-drugs-due-to-omicron/
Covid-19 Antibodies (Jan-Sep 2021):
$4.7B Regeneron
$1.1B Eli Lilly
REGN a fraction of LLY size
How’d they sell 4X+ as much antibody?
https://pharmaphorum.com/news/fda-bans-use-of-lilly-regeneron-covid-drugs-due-to-omicron/
Covid-19 Antibodies (Jan-Sep 2021):
$4.7B Regeneron
$1.1B Eli Lilly
REGN a fraction of LLY size
How’d they sell 4X+ as much antibody?